Baylor study on boosters awaits FDA
Recipients of the Johnson & Johnson COVID-19 vaccine may benefit from receiving a booster of any brand, according to a new Baylor-led study, the preliminary findings of which support a mix-and-match approach. The study, released last week ahead of Friday’s U.S. Food and Drug Administration hearing on booster shots, bolsters the case for the safety of mixing and matching vaccines to achieve protection from the virus’ most severe symptoms.